TEE 3D RV Assessment for SAVR, Mini AVR, and TAVR

NCT05804240 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 67

Last updated 2026-05-13

Study results available
· View outcomes & findings →

Summary

Three-dimensional echocardiography has become a gold standard to assess right ventricular (RV) function, and investigators plan to use 3D transesophageal echocardiography to assess RV function in 3 types of aortic valve replacement (AVR): full sternotomy surgical AVR (full-SAVR), mini-sternotomy surgical AVR (mini-SAVR), and transcatheter AVR (TAVR).

Conditions

  • Right Ventricular Dysfunction

Interventions

DIAGNOSTIC_TEST

3D TEE RVEF

With TEE package software, the investigators measure and calculate 3D TEE RVEF using mid esophageal 4 chamber view

Sponsors & Collaborators

  • Thomas Jefferson University

    lead OTHER

Principal Investigators

  • Yoshihisa Morita, MD · Thomas Jefferson University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-01
Primary Completion
2025-06-30
Completion
2025-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05804240 on ClinicalTrials.gov